Author

Antonio García‐Herola

Observed names: A García Herola, A García-Herola, A Garcı́a-Herola, A. Garcia-Herola, A. García Herola, A. García-Herola, Antonio Garcia-Herola, Antonio García Herola, Antonio García-Herola, Antonio Herola, García-Herola, Antonio

Institution: Hospital Marina Baixa

Observed institutions: Birmingham City Hospital, Hospital Universitari i Politècnic La Fe, Instituto Maimónides de Investigación Biomédica de Córdoba, Hospital Universitario Reina Sofía, Hospital General Universitario de Alicante Doctor Balmis, Hospital Marina Baixa, University of Córdoba

ORCID: 0000-0002-6755-4994

Observed ORCID: 0000-0002-6755-4994

OpenAlex ID: A5103205560

2000 · Marina Berenguer, Linda Ferrell, et al. · Journal of Hepatology · 753

High Incidence of Allograft Cirrhosis in Hepatitis C Virus Genotype 1B Infection Following Transplantation: Relationship With Rejection Episodes

1999 · Martín Prieto, Marina Berenguer, et al. · Hepatology · 536

Prevalence of Malnutrition and Nutritional Characteristics of Patients With Inflammatory Bowel Disease

2017 · María José Casanova, Maria Chaparro, et al. · Journal of Crohn s and Colitis · 208

Evolution After Anti-TNF Discontinuation in Patients With Inflammatory Bowel Disease: A Multicenter Long-Term Follow-Up Study

2016 · M J Casanova, M Chaparro, et al. · The American Journal of Gastroenterology · 114

PDF

Effectiveness and Safety of the Sequential Use of a Second and Third Anti-TNF Agent in Patients With Inflammatory Bowel Disease: Results From the Eneida Registry

2019 · María José Casanova, María Chaparro, et al. · Inflammatory Bowel Diseases · 54

PDF

Characteristics of hepatitis C virus resistance in an international cohort after a decade of direct-acting antivirals

2022 · Anita Y.M. Howe, Chaturaka Rodrigo, et al. · JHEP Reports · 49

PDF

Screening of hepatitis C virus infection in adult general population in Spain

2018 · Laura Gómez-Escolar Viejo, Antonio García Herola, et al. · European Journal of Gastroenterology & Hepatology · 44

Progression of cardiomyopathy and neuropathy after liver transplantation in a patient with familial amyloidotic polyneuropathy caused by tyrosine-77 transthyretin variant

1999 · Antonio García-Herola, Martín Prieto, et al. · Liver Transplantation and Surgery · 41

PDF

Comparison of staging systems to predict survival in hepatocellular carcinoma

2006 · Sonia Pascual, Pedro Zapater, et al. · Liver International · 28

PDF

2024 · Carla J. Gargallo-Puyuelo, Elena Ricart, et al. · Clinical Gastroenterology and Hepatology · 24

PDF

Incidence, characteristics, and predictive factors of post‐colonoscopy colorectal cancer

2024 · Sandra Baile‐Maxía, Carolina Mangas‐Sanjuan, et al. · United European Gastroenterology Journal · 23

PDF

Clinical and economic impact of an alert system in primary care for the detection of patients with chronic hepatitis C

2021 · Antonio García-Herola, Raquel Domínguez-Hernández, et al. · PLoS ONE · 19

PDF

Antitumor Necrosis Factor Agents to Treat Endoscopic Postoperative Recurrence of Crohn's Disease: A Nationwide Study With Propensity-Matched Score Analysis

2020 · Fiorella Cañete, Míriam Mañosa, et al. · Clinical and Translational Gastroenterology · 19

Relationship between smoking and colonic involvement in inflammatory bowel disease.

1998 · M Bustamante, P Nos, et al. · PubMed · 18

High efficacy of resistance-guided retreatment of HCV patients failing NS5A inhibitors in the real world

2019 · Ana Belén Pérez, Natalia Chueca, et al. · Journal of Hepatology · 16

PDF

Acute and chronic hemodynamic changes after propranolol in patients with cirrhosis under primary and secondary prophylaxis of variceal bleeding: a pilot study

2010 · Enrique de-Madaria, José María Palazón, et al. · European Journal of Gastroenterology & Hepatology · 12

Prevalence of resistance associated substitutions and efficacy of baseline resistance-guided chronic hepatitis C treatment in Spain from the GEHEP-004 cohort

2019 · Ana Belén Pérez, Natalia Chueca, et al. · PLoS ONE · 11

PDF

Impact of potential multiple drug-drug interactions on the adverse event profile of patients with hepatitis C treated with pangenotypic direct-acting antivirals in Spain

2024 · Juan Turnes, Antonio García-Herola, et al. · Revista Española de Sanidad Penitenciaria · 8

PDF

[Significance of the determination of antineutrophil cytoplasmic antibodies (ANCA) in ulcerative colitis and Crohn's disease].

1998 · A García-Herola, P Nos, et al. · PubMed · 8

Acute pancreatitis as the first manifestation of pancreatic Burkitt’s lymphoma in a patient infected by the human immunodeficiency virus

2001 · A.Jimeno Sainz, J.C Blázquez Encinar, et al. · The American Journal of Medicine · 6

Pyrimethamine/Sulfadoxine for Prevention of Pneumocystis carinii Pneumonia in Patients Infected with the Human Immunodeficiency Virus

1994 · R. Jurado, A. Garcia-Herola, et al. · Clinical Infectious Diseases · 4

Rifampin-Induced Severe Thrombocytopenia in a Patient with Pulmonary Tuberculosis

1994 · Jose M. Kindelán, I. Serrano, et al. · Annals of Pharmacotherapy · 3

Use of psychiatric medication and drug interactions in patients with hcv infection treated with pangenotypic direct-acting antivirals

2023 · J. Turnes, A. Garcia-Herola, et al. · Digestive and Liver Disease · 1

IDDF2022-ABS-0242 Risk of multiple drug interactions potentially linked to safety in patients receiving pangenotypic direct-acting antivirals for the treatment of hepatitis C

2022 · Juan Turnes, Antonio García-Herola, et al. · Gut · 1

P629 Long-term effectiveness and safety of ustekinumab (UST) in patients with active Crohn’s disease (CD) in real life: Interim analysis of the SUSTAIN study

2020 · M Chaparro, S Sulleiro, et al. · Journal of Crohn s and Colitis · 1

PDF

Works count: 43

Citation count: 2,002

H-index: 15

I10-index: 17